Login / Signup

Toxicity of internal mammary irradiation in breast cancer. Are concerns still justified in times of modern treatment techniques?

Kai Joachim BormCristoforo SimonettoPavel KundrátMarkus EidemüllerMarkus OechsnerMathias DüsbergStephanie Elisabeth Combs
Published in: Acta oncologica (Stockholm, Sweden) (2020)
According to our analyses, the published oncological benefit of IMNI outweighs the estimated risk of cardiac mortality even in case of (e.g., cardiac) risk factors during VMAT. The estimated risk of secondary cancer or pneumonitis attributed to IMNI is low. DIBH reduces the estimated additional risk of IMNI even further and should be strongly considered especially in patients with a high baseline risk.
Keyphrases